Clinical Trial Detail

NCT ID NCT02194738
Title Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Crizotinib

Erlotinib

Age Groups: senior adult

No variant requirements are available.